MENU
component-ddb-728x90-v1-01-desktop

FDA approves first drug to limit frequent waking to urinate

U.S. regulators have approved the first drug to reduce nighttime trips to the bathroom.

The treatment is a nasal spray intended for adults who wake up at least twice at night to urinate.

The Food and Drug Administration said Friday the spray -- called Noctiva -- is not approved to treat all causes of frequent nighttime urination, so doctors must determine the cause and best treatment for each person.

It is approved specifically for a condition caused by such things as chronic heart failure, poorly controlled diabetes and bladder and prostate problems, as well as some medications.

close video ad
Unmutetoggle ad audio on off

Trending